Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
[EN] COMPETITIVE AND NONCOMPETITIVE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5<br/>[FR] INHIBITEURS COMPÉTITIFS ET NON COMPÉTITIFS DU RÉCEPTEUR DE L'ACÉTYLCHOLINE MUSCARINIQUE M5